Evidence map›Paper›PMID 20666873›Full record

ArticleJournal of clinical periodontology2010

Association of salivary lysozyme and C-reactive protein with metabolic syndrome.

Markku Qvarnstrom, Sok-Ja Janket, Judith A Jones, Kamal Jethwani, Pekka Nuutinen, Raul I Garcia, Alison E Baird, Thomas E Van Dyke, Jukka H Meurman

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of clinical periodontology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Markku QvarnstromOtorhinolaryngology/Oral and Maxillofacial Surgery, Kuopio University, Kuopio, Finland.
Sok-Ja Janket
Judith A Jones
Kamal Jethwani
Pekka Nuutinen
Raul I Garcia
Alison E Baird
Thomas E Van Dyke
Jukka H Meurman
Boston University · USKuopio University Hospital · FISUNY Downstate Health Sciences University · USUniversity of Helsinki · FI

Funding

Specialized Center for Oral Inflammation and ResolutionP50DE016191 · NIDCR · BRIGHAM AND WOMEN'S HOSPITAL · PI SERHAN, CHARLES NICHOLAS · 2004 to 2010
$13.6M
Neutrophils and Periodontitis in DiabetesR01DE015566 · NIDCR · BOSTON UNIVERSITY MEDICAL CAMPUS · PI VAN DYKE, THOMAS ELLIOTT · 2005 to 2014
$4.2M
ORAL CONDITIONS AND SYSTEMIC HEALTH OUTCOMESK24DE000419 · NIDCR · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GARCIA, RAUL I · 1999 to 2008
$1.1M
Oral Health-Related Quality of Life in children and their FamiliesK24DE018211 · NIDCR · BOSTON UNIVERSITY MEDICAL CAMPUS · PI JONES, JUDITH A · 2007 to 2011
$905k
Prospective study of obesity and periodontal diseaseR01DE019833 · NIDCR · BOSTON UNIVERSITY MEDICAL CAMPUS · PI KAYE, ELIZABETH A · 2009 to 2011
$599k
NIDCR NIH HHS DE15566NIDCR NIH HHS DE DE16191NIDCR NIH HHS K24 DE000419NIDCR NIH HHS K24 DE018211NIDCR NIH HHS K24DE018211NIDCR NIH HHS P50 DE016191NIDCR NIH HHS R01 DE015566NIDCR NIH HHS R01 DE019833
6 · The paper itself

Abstract

introductionSalivary lysozyme (SLZ) is a proteolytic enzyme secreted by oral leucocytes and contains a domain that has an affinity to advanced glycation end products (AGE). Thus, we hypothesized that SLZ would be associated with metabolic syndrome (metS), a pro-inflammatory state.

methodsUtilizing cross-sectional data from 250 coronary artery disease (CAD) and 250 non-CAD patients, the association of SLZ with metS was tested by logistic regression analyses controlling for age, sex, smoking, total cholesterol and C-reactive protein (CRP) levels. The analyses were stratified by CAD status to control for the possible effects of CAD.

resultsMetS was found in 122 persons. The adjusted odds ratio (OR) for metS associated with the highest quartile of SLZ was 1.95 with 95% confidence interval (CI) 1.20-3.12, p-value=0.007, compared with the lower three quartiles combined. Among the 40 subjects with metS but without CAD, the OR was 1.63 (CI: 0.64-4.15, p=0.31), whereas in the CAD group, SLZ was significantly associated with metS [OR=1.96 (1.09-3.52), p=0.02]. In both subgroups, CRP was not significantly associated with metS.

conclusionSLZ was significantly associated with metS (OR=1.95) independent of CRP level. Future longitudinal research is warranted.

Indexed as

Age FactorsBlood GlucoseBlood PressureBody Mass IndexCase-Control StudiesCholesterolCholesterol, HDLCohort StudiesCoronary Artery DiseaseC-Reactive ProteinCross-Sectional StudiesFemaleHumansHypertensionMaleMetabolic SyndromeBlood GlucoseCholesterolCholesterol, HDLC-Reactive ProteinMuramidaseSalivary Proteins and PeptidesTriglycerides

Identifiers

PMID20666873
PMCPMC2923268
OpenAlexW1488665745

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.